on 24 Aug 2015
Last Applicant/ Owned by
Pronutria Biosciences, Inc.
840 Memorial Drive, Third Floor
Cambridge, , 02139
Serial Number
UK00914500722 filed on 24th Aug 2015
Registration Number
UK00914500722 registered on
18th Dec 2015
Correspondent Information
FREISCHEM & PARTNER PATENTANWÄLTE MBB
Salierring 47 - 53
Köln,
50677
Chemical substances, chemical materials and chemical preparations, and natural elements; proteins and polypeptides for use in scientific and medical research and in the preparation of biochemicals; nutrients and nutritive products, namely, proteins used in the manufacture of beverages, food products and food supplements for human and non-human animal use; biochemicals for in vitro and in vivo scientific research.
Medical and veterinary preparations and articles; pharmaceutical preparations and substances for the treatment of diseases, disorders and conditions associated with muscle wasting and protein energy dysfunction, neurological diseases, hepatic diseases and metabolic diseases; proteins and polypeptides being a featured component of pharmaceutical preparations; dietary supplements and dietetic preparations; dietary and nutritional supplements for human consumption; medical foods, defined as foods which are formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation; nutraceuticals for use as a dietary supplement; protein dietary supplements; dietary food supplements for human and non-human animal use.
Medical and pharmacological research services; development of pharmaceutical preparations and medicines, and dietary and nutritional foods and supplements; characterization of metrics and biomarkers, namely development and evaluation of assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment and prevention of diseases, disorders and conditions associated with muscle wasting and protein energy dysfunction, neurological diseases, hepatic diseases and metabolic diseases.
UK00914500722
Word
Individual